Outlook Therapeutics Cash from Financing (TTM) Analysis

Outlook Therapeutics Inc (OTLK)

8.58 -0.02 (-0.23%) USD | NASDAQ | May 06, 11:43

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2015. Upgrade now.

Date	Value
December 31, 2023	5.120M
September 30, 2023	48.97M
June 30, 2023	48.17M
March 31, 2023	33.57M
December 31, 2022	36.78M
September 30, 2022	59.59M
June 30, 2022	61.74M
March 31, 2022	75.76M
December 31, 2021	116.50M
September 30, 2021	56.19M
June 30, 2021	53.08M
March 31, 2021	76.52M
December 31, 2020	43.58M
September 30, 2020	37.21M
June 30, 2020	36.48M
March 31, 2020	34.65M
December 31, 2019	30.49M

Date	Value
September 30, 2019	39.03M
June 30, 2019	38.67M
March 31, 2019	28.91M
December 31, 2018	22.48M
September 30, 2018	34.35M
June 30, 2018	37.76M
March 31, 2018	28.97M
December 31, 2017	31.31M
September 30, 2017	16.63M
June 30, 2017	13.14M
March 31, 2017	34.58M
December 31, 2016	36.69M
September 30, 2016	39.86M
June 30, 2016	58.36M
March 31, 2016	49.64M
December 31, 2015	48.22M
September 30, 2015	43.00M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

5.120M

Minimum

Dec 2023

116.50M

Maximum

Dec 2021

49.06M

Average

43.58M

Median

Dec 2020

Cash from Financing (TTM) Benchmarks